Sponsor Pipeline

Bisirna Therapeutics (Suzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07551505 Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) Dyslipidemias Not Yet Recruiting
NCT06766929 A Phase I Clinical Study of VSA012 in Healthy Volunteers Healthy Volunteers Active, Not Recruiting
Get alerts when Bisirna Therapeutics (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free